SCHEMBL7306463

SCHEMBL7306463

O=C1CN2Cc3c(Cl)cccc3N=C2N1

nearest known ligand 0.70

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 17/20 0.70
PDE3A Q14432 17/20 0.70
MEN1 O00255 1/20 0.70
PDE2A O00408 1/20 0.70
KMT2A Q03164 1/20 0.70
P2RY12 Q9H244 1/20 0.70
CYP1A2 P05177 2/20 0.56
TSHR P16473 2/20 0.56
LMNA P02545 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
BLM P54132 1/20 0.56
ACHE P22303 1/20 0.48
CTSD P07339 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927003 0.82 PDE3B (0.60) PDE3BPDE3AMEN1PDE2AKMT2A
SCHEMBL1570572 0.82 PDE3B (0.60) PDE3BPDE3AMEN1PDE2AKMT2A
Anagrelide SCHEMBL5060881 0.82 PDE3B (1.00) PDE3BPDE3AMEN1PDE2AKMT2A
Anagrelide SCHEMBL9411 0.82 PDE3B (1.00) PDE3BPDE3AMEN1PDE2AKMT2A
SCHEMBL1570935 0.82 PDE3B (0.60) PDE3BPDE3AMEN1PDE2AKMT2A
Anagrelide SCHEMBL1449704 0.81 PDE3B (0.97) PDE3BPDE3AMEN1PDE2AKMT2A
Anagrelide SCHEMBL1568712 0.81 PDE3B (0.97) PDE3BPDE3AMEN1PDE2AKMT2A
Anagrelide SCHEMBL9046734 0.81 PDE3B (0.97) PDE3BPDE3AMEN1PDE2AKMT2A
Hydrochloric Acid SCHEMBL10605149 0.81 PDE3B (0.58) PDE3BPDE3AMEN1PDE2AKMT2A
Anagrelide SCHEMBL318593 0.81 PDE3B (0.97) PDE3BPDE3AMEN1PDE2AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144761-A1 PROCESS FOR THE PREPARATION OF ANAGRELIDE HYDROCHLORIDE MONOHYDRATE PIRAMAL PHARMA LIMITED (IN) 2023-08-03 WO disclosed
EP-2981537-B1 PROCESS FOR MAKING ANAGRELIDE SYNTHON BV (NL) 2017-05-10 EP disclosed
WO-2014206484-A1 PROCESS FOR MAKING ANAGRELIDE SYNTHON B.V. (NL) 2014-12-31 WO disclosed
WO-2014139572-A1 PROCESS FOR MAKING ANAGRELIDE SYNTHON BV (NL) 2014-09-18 WO disclosed
US-RE31617-E ANTICOAGULANTS; HYPOTENSIVE AND BRONCHODILATOR AGENTS BRISTOL-MYERS COMPANY (US) 1984-06-26 US disclosed
US-3932407-A BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTICOAGULANTS BRISTOL-MYERS COMPANY (US) 1976-01-13 US disclosed